20
Estechpharma Co., Ltd. Kyonggi-do Kr, based in South Korea, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their significant offerings is Triflusal, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R1-CEP 2004-195 - Rev 01
This Chemical Type CEP, issued on January 13, 2012, remains in force until April 11, 2013, ensuring its reliability within the pharmaceutical industry.
Substance Number 1377 associated with this CEP further emphasizes